Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
What Successful People Do Differently With Money
Learn the key money moves successful people make, from goal setting to conscious spending and informed investing that build lasting wealth.
12,910 articlesSunrun Surges on 16-Gigawatt Virtual Power Plant Deal
Sunrun jumped on news of a large-scale virtual power plant deal with Tesla and Renew Home, signaling a shift in distr...
Apple's Target Climbs Earnings as Double-Digit Upside Looms
Apple reported a strong quarter with better-than-expected growth across iPhone and Services. Analysts say apple’s tar...
Newsom Calls National Billionaires’ Tax Plan Across U.S.
California Gov. Gavin Newsom unveils a national wealth tax plan and a federal stake in AI firms, as a California ball...
What Savara Investors Should Know About 580K Options
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
Where Will Cerebras Stock Be in 3 Years? A Practical Guide
Curious about Cerebras stock and its three-year outlook? This guide breaks down growth drivers, risks, and three scen...
Forget SanDisk: This Coiled-Spring Titan Bets Big on AI Memory
A fresh memory company touts a coiled-spring architecture to outpace NAND rivals amid AI-driven demand, sparking a co...
S&P 500: Posted Best Quarterly Performance Signals More Gains
When the S&P 500 posted best quarterly performance, markets flashed a signal that traders will debate for weeks. This...
Is Equinix Infrastructure Stock Investors Watching AI Growth
As AI moves from experiments to real workloads, the need for secure, low-latency data paths grows. This look explores...
Cloudflare Positioning for the AI Era: A New Playbook
Cloudflare signals a bold pivot to AI-enabled edge infrastructure, reorganizing around AI and cutting roughly one-fif...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Nuscale Power Down 2026: One Buy Reason, Two Wait Reasons
As electricity demand climbs, NuScale Power presents a rare risk reward. This piece lays out one compelling buy reaso...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status